, Volume 115, Issue 1–2, pp 37–45 | Cite as

Differential regulation of the behavioral effects of chlordiazepoxide

  • Jed S. Shumsky
  • Irwin Lucki
Original Investigations


Chronic administration of the benzodiazepine (BZ) receptor agonist chlordiazepoxide (CDP) produced tolerance to its motor-impairing effects but little or no tolerance to its hypothermic effects or to its amnesic effects in the radial arm maze. Male Sprague-Dawley rats were pretreated for 14 days with CDP (25 mg/kg, b.i.d., IP) or saline, and chronic treatment was maintained throughout the experiments. Tolerance was evaluated by constructing dose-response curves to CDP following chronic administration of either CDP or saline. Tolerance developed to only certain behavioral effects of CDP. Tolerance developed to the motor-impairing effects of CDP as assessed in three different procedures: rotarod, spontaneous locomotor activity, and acquisition of the step-through inhibitory avoidance response. In contrast, tolerance did not develop to the hypothermic effects of CDP. Tolerance to the amnesic effects of CDP was contingent upon the behavioral procedure. For example, tolerance developed to reductions of retention latency in the step-through inhibitory avoidance response, but not to impairment of the acquisition of radial arm maze performance. These results are consistent with the effects of chronic BZ administration in humans and demonstrate a parallel regulation of drug effects, potentially mediated by regional differences in BZ receptor subtype regulation or composition.

Key words

Amnesia Benzodiazepine Chlordiazepoxide Hypothermia Inhibitory avoidance Locomotor activity Radial arm maze Rotarod Tolerance 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Aranko K, Mattila MJ, Nuutila A, Pellinen J (1985) Benzodiazepines, but not antidepressants or neuroleptics, induce dosedependent development of tolerance to lorazepam in psychiatric patients. Acta Psychiatr Scand 72:436–446Google Scholar
  2. Chan AWK, Langan MC, Schanley DL, Penetrante ML, Leong FW, Aldrich-Castanick L (1988) Differential effects of RO15-1788 in actions of chlordiazepoxide and ethanol. Pharmacol Biochem Behav 29:315–320Google Scholar
  3. Christensen JD (1973) Tolerance development with chlordiazepoxide in relation to the plasma levels of the parent compound and its main metabolites in mice. Acta Pharmacol Toxicol 33:267–272Google Scholar
  4. Cook L, Sepinwall J (1975) Behavioural analysis of the effects and mechanisms of action of benzodiazepines. In: Costa E, Greengard P (eds) Mechanism of action of benzodiazepines. Raven Press, New York, pp 1–28Google Scholar
  5. Cooper SJ, Burnett G, Brown K (1981) Food preference following acute or chronic chlordiazepoxide administration: tolerance to an antineophobic action. Psychopharmacology 73:70–74Google Scholar
  6. Crawford TO, Mitchell WG, Snodgrass SR (1987) Lorazepam in childhood status epilepticus and serial seizures: effectiveness and tachyphylaxis. Neurology 37:190–195Google Scholar
  7. File SE (1982) Development and retention of tolerance to the sedative effects of chlordiazepoxide: role of apparatus cues. Eur J Pharmacol 81:637–643Google Scholar
  8. File SE (1984) Behavioural pharmacology of benzodiazepines. Prog Neuropsychopharmacol Biol Psychiatry 8:19–31Google Scholar
  9. File SE (1985) Tolerance to the behavioral actions of benzodiazepines. Neurosci Biobehav Rev 9:113–121Google Scholar
  10. Gey KF (1973) Effect of benzodiazepines on carbohydrate metabolism in rat brain. In: Garattini S, Mussini E, Randall LO (eds) The benzodiazepines. Raven Press, New York, pp 243–255Google Scholar
  11. Goldberg ME, Manian AA, Efron DH (1967) A comparative study of certain pharmacological responses following acute and chronic administrations of chlordiazepoxide. Life Sci 6:481–491Google Scholar
  12. Heninger C, Saito N, Tallman JF, Garrett KM, Vitek MP, Duman RS, Gallager DW (1990) Effects of continuous diazepam administration of GABAA subunit mRNA in rat brain. J Mol Neurosci 2:101–107Google Scholar
  13. Hoogland DR, Miya TS, Bousquet WF (1966) Metabolism and tolerance studies with CDP-2-14C in the rat. Toxicol Appl Pharmacol 9:116–123Google Scholar
  14. Kang I, Miller LG (1991) Decreased GABAA receptor subunit mRNA concentrations following chronic lorazepam administration. Br J Pharmacol 103:1285–1287Google Scholar
  15. Lucki I, Rickels K (1988) The effect of anxiolytic drugs on memory in anxious subjects. In: Hindmarch I, Ott H (eds) Benzodiazepine receptor ligands, memory and information processing, Springer, New York, pp 128–139Google Scholar
  16. Lucki I, Rickels K, Geller AM (1986) Chronic use of benzodiazepines and psychomotor and cognitive test performance. Psychopharmacology 88:426–433Google Scholar
  17. Lucki I, Ward HR, Frazer A (1989) The effect of 1-(m-chlorphenyl)piperazine (m-CPP) and 1-(m-trifluoromethylphenyl)-piperazine (TFMPP) on locomotor activity. J Pharmacol Exp Ther 249:155–164Google Scholar
  18. Magar ME (1972) Minimization of functions. In: Data analysis in biochemistry and biophysics. Academic Press, New York, pp 93–166Google Scholar
  19. Margules DL, Stein L (1968) Increase of “anti-anxiety” activity and tolerance of behavioral depression during chronic administration of oxazepam. Psychopharmacologia 13:74–80Google Scholar
  20. Massoti M, Schlichting JL, Antonacci MD, Giusti P, Memo M, Costa E, Guidotti A (1991) γ -Aminobutyric acidA receptor heterogeneity in rat central nervous system: studies with clonazepam and other benzodiazepine ligands. J Pharmacol Exp Ther 256:1154–1160Google Scholar
  21. McMillan DE, Leander JD (1978) Chronic chlordiazepoxide and pentobarbital interactions on punished and unpunished behavior. J Pharmacol Exp Ther 207:515–520Google Scholar
  22. Miller LG, Greenblatt DJ, Barnhill JG, Shader RI (1988) Chronic benzodiazepine administration I. Tolerance is associated with benzodiazepine receptor downregulation and decreased γ-aminobutyric acidA receptor function. J Pharmacol Exp Ther 246:170–176Google Scholar
  23. Rickels K, Case WG, Downing RW, Winokur A (1983) Long-term diazepam therapy and clinical outcome. JAMA 250:767–771Google Scholar
  24. Rosenberg HC, Chiu TH (1981a) Tolerance during chronic benzodiazepine treatment associated with decreased receptor binding. Eur J Pharmacol 70:453–460Google Scholar
  25. Rosenberg HC, Chiu TH (1981b) Regional specificity of benzodiazepine receptor down-regulation during chronic treatment of rats with flurazepam. Neurosci Lett 24:49–52Google Scholar
  26. Ryan GP, Boisse NR (1983) Experimental induction of benzodiazepine tolerance and physical dependence. J Pharmacol Exp Ther 226:100–107Google Scholar
  27. Schuster CR, Dockens WS, Woods JH (1966) Behavioral variables affecting the development of amphetamine tolerance. Psychopharmacologia 9:170–182Google Scholar
  28. Shumsky JS, Lucki I (1991) Amnesic effects in the radial arm maze. Soc Neurosci Abstr 17:1586Google Scholar
  29. Shumsky JS, Lucki I (1992) Differential regulation of the behavioral effects of chlordiazepoxide. Soc Neurosci Abstr 18:358Google Scholar
  30. Thiebot MH (1985) Some evidence for amnesic-like effects of benzodiazepines in animals. Neurosci Biobehav Rev 9:95–100Google Scholar
  31. Tietz EI, Rosenberg HC, Chiu TH (1986) Autoradiographic localization of benzodiazepine receptor downregulation. J Pharmacol Exp Ther 236:284–292Google Scholar
  32. Tietz EI, Chiu TH, Rosenberg HC (1989) Regional GABA/benzodiazepine receptor/chloride channel coupling after acute and chronic benzodiazepine treatment. Eur J Pharmacol 167:57–65Google Scholar
  33. Wilson MA, Gallager DW (1988) GABAergic subsensitivity of dorsal raphe neurons in vitro after chronic benzodiazepine treatment in vivo. Brain Res 473:198–202Google Scholar
  34. Wilson MA, Gallager DW (1989) Responses of substantia nigra pars reticulata neurons to benzodiazepine ligands after acute and prolonged diazepam exposure I: Modulation of γ-aminobutyric acid sensitivity. J Pharmacol Exp Ther 248:879–885Google Scholar
  35. Wisden W, Laurie DJ, Monyer H, Seeburg PH (1992) The distribution of 13 GABAA receptor subunit mRNAs in the rat brain. I. Telencephalon, diencephalon, mesencephalon. J Neurosci 12:1040–1062Google Scholar

Copyright information

© Springer-Verlag 1994

Authors and Affiliations

  • Jed S. Shumsky
    • 1
  • Irwin Lucki
    • 1
    • 2
  1. 1.Department of PharmacologyUniversity of PennsylvaniaPhiladelphiaUSA
  2. 2.Department of PsychiatryUniversity of PennsylvaniaPhiladelphiaUSA

Personalised recommendations